Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022

SELL
$225.82 - $368.51 $45,164 - $73,702
-200 Reduced 16.67%
1,000 $254,000
Q3 2021

Oct 15, 2021

BUY
$221.9 - $484.47 $155,330 - $339,129
700 Added 140.0%
1,200 $462,000
Q3 2020

Oct 13, 2020

BUY
$54.34 - $94.85 $27,170 - $47,425
500 New
500 $35,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Spirit Of America Management Corp Portfolio

Follow Spirit Of America Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spirit Of America Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Spirit Of America Management Corp with notifications on news.